Logo image of ABM.CA

ABEN GOLD CORP (ABM.CA) Stock Fundamental Analysis

TSX-V:ABM - CA0029381088 - Common Stock

0.07 CAD
+0.01 (+7.69%)
Last: 8/29/2025, 7:00:00 PM
Fundamental Rating

1

Taking everything into account, ABM scores 1 out of 10 in our fundamental rating. ABM was compared to 803 industry peers in the Metals & Mining industry. ABM scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ABM has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

ABM had negative earnings in the past year.
In the past year ABM has reported a negative cash flow from operations.
In the past 5 years ABM always reported negative net income.
In the past 5 years ABM always reported negative operating cash flow.
ABM.CA Yearly Net Income VS EBIT VS OCF VS FCFABM.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -500K -1M -1.5M

1.2 Ratios

ABM's Return On Assets of -4.06% is fine compared to the rest of the industry. ABM outperforms 74.22% of its industry peers.
The Return On Equity of ABM (-4.15%) is better than 76.96% of its industry peers.
Industry RankSector Rank
ROA -4.06%
ROE -4.15%
ROIC N/A
ROA(3y)-5.27%
ROA(5y)-5.87%
ROE(3y)-5.3%
ROE(5y)-5.92%
ROIC(3y)N/A
ROIC(5y)N/A
ABM.CA Yearly ROA, ROE, ROICABM.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 -2 -4 -6 -8

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ABM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ABM.CA Yearly Profit, Operating, Gross MarginsABM.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024

4

2. Health

2.1 Basic Checks

ABM has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for ABM is higher compared to a year ago.
ABM.CA Yearly Shares OutstandingABM.CA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M 15M
ABM.CA Yearly Total Debt VS Total AssetsABM.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

ABM has an Altman-Z score of -0.23. This is a bad value and indicates that ABM is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.23, ABM is in line with its industry, outperforming 42.34% of the companies in the same industry.
A Debt/Equity ratio of 0.02 indicates that ABM is not too dependend on debt financing.
The Debt to Equity ratio of ABM (0.02) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z -0.23
ROIC/WACCN/A
WACCN/A
ABM.CA Yearly LT Debt VS Equity VS FCFABM.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 5M 10M

2.3 Liquidity

A Current Ratio of 6.65 indicates that ABM has no problem at all paying its short term obligations.
With an excellent Current ratio value of 6.65, ABM belongs to the best of the industry, outperforming 80.20% of the companies in the same industry.
A Quick Ratio of 6.65 indicates that ABM has no problem at all paying its short term obligations.
The Quick ratio of ABM (6.65) is better than 80.20% of its industry peers.
Industry RankSector Rank
Current Ratio 6.65
Quick Ratio 6.65
ABM.CA Yearly Current Assets VS Current LiabilitesABM.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 500K 1M 1.5M

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 53.97% over the past year.
EPS 1Y (TTM)53.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2.15%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ABM. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ABM.CA Price Earnings VS Forward Price EarningsABM.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ABM.CA Per share dataABM.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ABM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ABEN GOLD CORP

TSX-V:ABM (8/29/2025, 7:00:00 PM)

0.07

+0.01 (+7.69%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)08-21 2025-08-21
Earnings (Next)01-21 2026-01-21
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners7.27%
Ins Owner ChangeN/A
Market Cap1.63M
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.12
P/tB 0.12
EV/EBITDA N/A
EPS(TTM)-0.03
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS0.58
TBVpS0.58
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.06%
ROE -4.15%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-5.27%
ROA(5y)-5.87%
ROE(3y)-5.3%
ROE(5y)-5.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.65
Quick Ratio 6.65
Altman-Z -0.23
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)53.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2.15%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y29.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y7.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y14.54%
OCF growth 3YN/A
OCF growth 5YN/A